Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001584145-25-000006
Filing Date
2025-10-30
Accepted
2025-10-30 16:39:31
Documents
1
Period of Report
2025-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1761856769.html 4  
1 FORM 4 wk-form4_1761856769.xml 4 3285
  Complete submission text file 0001584145-25-000006.txt   4874
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO X1 94080
Business Address
Wygant Jonathan (Reporting) CIK: 0001584145 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 251436339